The Washington Post says it has obtained documents that detail the five-year experiment involving state Medicaid programs and Medicare Part D plans. Plus: CMS has bumped up Medicare payments for ...

Researchers saw significant increases in testosterone levels for men with obesity or Type 2 diabetes while taking GLP-1 medications, The Hill wrote. Also in the news: vaping, PFAS, junk food, and more ...

Eli Lilly (NYSE:LLY) stock rose 1.3% and Novo Nordisk (NYSE:NVO) shares jumped 2% Friday morning after The Washington Post reported that Medicare and Medicaid programs are planning to experiment with ...

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock gain as Trump administration to trial Medicare, Medicaid coverage for ...

Global pharmaceutical stocks dropped after President Trump wrote to 17 companies asking them to [cut the costs of drugs]( ...

The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...

Employers are bracing for higher health insurance premiums in 2026, with some reports of double digit percentage hikes.

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...